Here, we report a facile, versatile and simple one-pot synthesis of doxorubicin (Dox) loaded gold nanoparticles (Dox–GNP conjugate), where Dox can act both as a reducing as well as a capping agent.
No takes yet. Share an insight, caveat, or question.
Chaudhary et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: